Datopotamab deruxtecan

• Description :

  Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2) -targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Topoisomerase | Antibody-Drug Conjugates (ADCs)

• CAS Number :

  2238831-60-0